Literature DB >> 7138507

Characterization of human placental neuraminidases. Stability, substrate specificity and molecular weight.

D McNamara, G Beauregard, H V Nguyen, D L Yan, M Bélisle, M Potier.   

Abstract

1. At least two components of neuraminidase can be distinguished on the basis of thermolability and sedimentability by using the artificial fluorogenic substrate 4-methylumbelliferyl N-acetyl-alpha-D-neuraminate. 2. In crude homogenates, thermodenaturation at 25 degrees C showed a biphasic curve corresponding to component A (half-life, 21 min) and B (half-life, 85 min). The two components were partially resolved by centrifugation. A being soluble and B sedimentable. Both had similar pH-activity curves (pH optimum, 4.4), Km values (A, 0.10 mM; B, 0.06 mM) and molecular weight as determined by radiation inactivation (A, 67000; B, 63000). 3. The soluble A form was still aggregated or bound to membranous debris since almost all neuraminidase activity was eluted near or at the void volume of a Sephacryl S-300 column. 4. Both soluble and sedimentable fractions of placenta hydrolysed the GD1A ganglioside and N-acetyl-neuraminyl-D-lactose linearly for 12 h but no fetuin hydrolysis was detected. 5. The neuraminidase activity with the artificial fluorogenic substrate was inhibited by N-acetylneuraminyl-D-lactose but not by the GD1A ganglioside. These preliminary results suggest that there exist two closely related enzymes hydrolysing both the artificial substrate and N-acetylneuraminyl-D-lactose and a third one hydrolysing the GD1A ganglioside exclusively.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138507      PMCID: PMC1158487          DOI: 10.1042/bj2050345

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Membrane-bound neuraminidases of rat liver. Neuraminidase activity in Golgi apparatus.

Authors:  C S Kishore; D R Tulsiani; V P Bhavanandan; R Carubelli
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Studies on brain cytosol neuraminadase. I. Isolation and partial characterization of two forms of the enzyme from pig brain.

Authors:  B Venerando; G Tettamanti; B Cestaro; V Zambotti
Journal:  Biochim Biophys Acta       Date:  1975-10-22

4.  Sialidase activity in transformed cells.

Authors:  C L Schengrund; R N Lausch; A Rosenberg
Journal:  J Biol Chem       Date:  1973-06-25       Impact factor: 5.157

5.  Localization of sialidase in the plasma membrane of rat liver cells.

Authors:  C L Schengrund; D S Jensen; A Rosenberg
Journal:  J Biol Chem       Date:  1972-05-10       Impact factor: 5.157

6.  The purification and properties of a mammalian neuraminidase (sialidase).

Authors:  J F Tallman; R O Brady
Journal:  Biochim Biophys Acta       Date:  1973-02-15

7.  On the lysosomal occurrence and the properties of the neuraminidase of rat liver and of Ehrlich ascites tumor cells.

Authors:  A Horvat; O Touster
Journal:  J Biol Chem       Date:  1968-08-25       Impact factor: 5.157

8.  Digestive activity of lysosomes. II. The digestion of macromolecular carbohydrates by extracts of rat liver lysosomes.

Authors:  N N Aronson; C De Duve
Journal:  J Biol Chem       Date:  1968-09-10       Impact factor: 5.157

9.  Studies on the soluble and lysosomal neuraminidases of rat liver.

Authors:  D R Tulsiani; R Carubelli
Journal:  J Biol Chem       Date:  1970-04-10       Impact factor: 5.157

10.  Human brain sialidase.

Authors:  R Ohman; A Rosenberg; L Svennerholm
Journal:  Biochemistry       Date:  1970-09-15       Impact factor: 3.162

View more
  1 in total

1.  Structure of the lysosomal neuraminidase-beta-galactosidase-carboxypeptidase multienzymic complex.

Authors:  M Potier; L Michaud; J Tranchemontagne; L Thauvette
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.